Cost-Effectiveness of Initiating Pharmacological Treatment in Stage One Hypertension Based on 10-Year Cardiovascular Disease Risk: A Markov Modeling Study. (2021)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/hypertensionaha.120.14913

PubMed Identifier: 33342242

Publication URI: http://europepmc.org/abstract/MED/33342242

Type: Journal Article/Review

Volume: 77

Parent Publication: Hypertension (Dallas, Tex. : 1979)

Issue: 2

ISSN: 0194-911X